- Home
- QMMM vs OBIO Comparison
QMMM vs OBIO Comparison
Compare QMMM & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMMM
- OBIO
- Stock Information
- Founded
- QMMM 2005
- OBIO 2017
- Country
- QMMM Hong Kong
- OBIO United States
- Employees
- QMMM N/A
- OBIO N/A
- Industry
- QMMM
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- QMMM
- OBIO Health Care
- Exchange
- QMMM NYSE
- OBIO Nasdaq
- Market Cap
- QMMM 196.2M
- OBIO 200.1M
- IPO Year
- QMMM 2024
- OBIO N/A
- Fundamental
- Price
- QMMM $7.33
- OBIO $5.84
- Analyst Decision
- QMMM
- OBIO Strong Buy
- Analyst Count
- QMMM 0
- OBIO 4
- Target Price
- QMMM N/A
- OBIO $15.75
- AVG Volume (30 Days)
- QMMM 1.3M
- OBIO 57.1K
- Earning Date
- QMMM 11-26-2024
- OBIO 11-12-2024
- Dividend Yield
- QMMM N/A
- OBIO N/A
- EPS Growth
- QMMM N/A
- OBIO N/A
- EPS
- QMMM N/A
- OBIO N/A
- Revenue
- QMMM $3,510,653.00
- OBIO $2,647,000.00
- Revenue This Year
- QMMM N/A
- OBIO $7.68
- Revenue Next Year
- QMMM N/A
- OBIO $110.40
- P/E Ratio
- QMMM N/A
- OBIO N/A
- Revenue Growth
- QMMM 20.09
- OBIO N/A
- 52 Week Low
- QMMM $3.00
- OBIO $4.22
- 52 Week High
- QMMM $13.00
- OBIO $11.69
- Technical
- Relative Strength Index (RSI)
- QMMM N/A
- OBIO 51.19
- Support Level
- QMMM N/A
- OBIO $5.56
- Resistance Level
- QMMM N/A
- OBIO $6.50
- Average True Range (ATR)
- QMMM 0.00
- OBIO 0.53
- MACD
- QMMM 0.00
- OBIO 0.00
- Stochastic Oscillator
- QMMM 0.00
- OBIO 56.58
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly-owned subsidiaries. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.